Edwards Lifesciences Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 153.30 M

Edwards Lifesciences Corporation Depreciation And Amortization is USD 153.30 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.44% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Edwards Lifesciences Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 148.20 M, a 5.78% change year over year.
  • Edwards Lifesciences Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 140.10 M, a 2.19% change year over year.
  • Edwards Lifesciences Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 137.10 M, a 19.11% change year over year.
  • Edwards Lifesciences Corporation Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 115.10 M, a 31.54% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased